Skip to main content

Byrne Asset Management LLC

Position in NVO — Novo Nordisk A S

CIK 1911322 KINGSTON, NJ

Position in NVO

as of Jun 30, 2026 · filed Jul 7, 2026
Position Value
$133,512
+$31,164 QoQ
Shares Held
2,785
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,057
of 1,348 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Byrne Asset Management LLC holds $7,638,539 across 9 Drug Manufacturers - General names. NVO ranks #8 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVO
Novo Nordisk A S
This page
2,785 $133,512

All Filings in NVO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $133,512 2,785
2026-03-31 $102,348 2,785
2025-12-31 $183,269 3,602
2025-09-30 $199,874 3,602
2025-06-30 $257,237 3,727
2025-03-31 $264,010 3,802
2024-12-31 $358,445 4,167
2024-09-30 $519,145 4,360
2024-06-30 $679,727 4,762
2024-03-31 $621,070 4,837
2023-12-31 $497,594 4,810
2023-09-30 $444,514 4,888
2023-06-30 $395,512 2,444
2023-03-31 $404,056 2,539
2022-12-31 $341,056 2,520
2022-09-30 $283,945 2,850
2022-06-30 $317,575 2,850
2022-03-31 $327,597 2,950
2021-12-31 $330,400 2,950